Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan-Feb;22(1):92-96.
doi: 10.4103/JCD.JCD_511_18.

A 1-year comparative evaluation of clinical performance of nanohybrid composite with Activa™ bioactive composite in Class II carious lesion: A randomized control study

Affiliations

A 1-year comparative evaluation of clinical performance of nanohybrid composite with Activa™ bioactive composite in Class II carious lesion: A randomized control study

Dhaval Bhadra et al. J Conserv Dent. 2019 Jan-Feb.

Abstract

Aim: The aim of this study was to compare and evaluate the clinical performance of nanohybrid composite with Activa™ bioactive composites in Class II carious lesion.

Methodology: After ethical approval, patients were selected according to the inclusion-exclusion criteria with minimum of two carious lesions in a single patient. Lesions were randomly divided into two groups: Group A - nanohybrid composite and Group B - Activa™ bioactive composite. After administration of local anesthetic agent, Class II cavity preparation was done followed by rubber dam application. For deep lesion, pulp protection was done with light-cured calcium hydroxide. Then, the cavities were restored. Finishing and polishing were done. Evaluation of the restorations was done at 1 week, 6 months, and 1 year time interval by second-blinded examiner according to the modified USPHS criteria. The results of the study were tabulated, and statistical analysis was done.

Results: The results showed no statistically significant difference in the clinical performance of nanohybrid composite and Activa™ bioactive composites in Class II carious lesions at the end of 1 week, 6 months, and 1 year.

Conclusion: It can be concluded that both materials showed equal and acceptable clinical performance at the end of 1 year. Both materials can be successfully be used to restore Class II carious lesions.

Keywords: Activa™ bioactive composites; Class II lesion; clinical evaluation; nanohybrid composite.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

Cited by

References

    1. Agrawal VS, Parekh VV, Shah NC. Comparative evaluation of microleakage of silorane-based composite and nanohybrid composite with or without polyethylene fiber inserts in class II restorations: An in vitro study. Oper Dent. 2012;37:E1–7. - PubMed
    1. Ergücü Z, Türkün LS. Clinical performance of novel resin composites in posterior teeth: 18-month results. J Adhes Dent. 2007;9:209–16. - PubMed
    1. Fortin D, Vargas MA. The spectrum of composites: New techniques and materials. J Am Dent Assoc. 2000;131(Suppl):26S–30S. - PubMed
    1. Arhun N, Celik C, Yamanel K. Clinical evaluation of resin-based composites in posterior restorations: Two-year results. Oper Dent. 2010;35:397–404. - PubMed
    1. Sadeghi M, Lynch CD, Shahamat N. Eighteen-month clinical evaluation of microhybrid, packable and nanofilled resin composites in class I restorations. J Oral Rehabil. 2010;37:532–7. - PubMed